164 related articles for article (PubMed ID: 32478743)
1. Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis.
Okurowska K; Roy S; Thokala P; Partridge L; Garg P; MacNeil S; Monk PN; Karunakaran E
J Vis Exp; 2020 May; (159):. PubMed ID: 32478743
[TBL] [Abstract][Full Text] [Related]
2. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
3. N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
Teuchner B; Eitzinger C; Lutz M; Hager T; Schmid E; Bechrakis NE; Zuck M; Jekle A; Debabov D; Anderson M; Nagl M
Acta Ophthalmol; 2012 Dec; 90(8):e632-7. PubMed ID: 22971221
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Activity of Poly-epsilon-lysine Peptide Hydrogels Against Pseudomonas aeruginosa.
Kennedy SM; Deshpande P; Gallagher AG; Horsburgh MJ; Allison HE; Kaye SB; Wellings DA; Williams RL
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):18. PubMed ID: 32776141
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies.
Zhu H; Kochevar IE; Behlau I; Zhao J; Wang F; Wang Y; Sun X; Hamblin MR; Dai T
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):586-593. PubMed ID: 28129422
[TBL] [Abstract][Full Text] [Related]
6. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
[No Abstract] [Full Text] [Related]
7. A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.
Chojnacki M; Philbrick A; Scherzi T; Pecora N; Dunman PM; Wozniak RAF
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332071
[TBL] [Abstract][Full Text] [Related]
8. Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.
Clemens LE; Jaynes J; Lim E; Kolar SS; Reins RY; Baidouri H; Hanlon S; McDermott AM; Woodburn KW
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6273-6281. PubMed ID: 29242901
[TBL] [Abstract][Full Text] [Related]
9. Increased tolerance to commonly used antibiotics in a
Okurowska K; Monk PN; Karunakaran E
Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739119
[No Abstract] [Full Text] [Related]
10. Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model.
Frucht-Pery J; Golan G; Hemo I; Zauberman H; Shapiro M
Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):532-4. PubMed ID: 8537030
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic considerations in the treatment of bacterial keratitis.
Callegan MC; O'Callaghan RJ; Hill JM
Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
[TBL] [Abstract][Full Text] [Related]
12. Melimine-Coated Antimicrobial Contact Lenses Reduce Microbial Keratitis in an Animal Model.
Dutta D; Vijay AK; Kumar N; Willcox MD
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5616-5624. PubMed ID: 27768798
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo rabbit and human corneas as models for bacterial and fungal keratitis.
Pinnock A; Shivshetty N; Roy S; Rimmer S; Douglas I; MacNeil S; Garg P
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):333-342. PubMed ID: 27844206
[TBL] [Abstract][Full Text] [Related]
14. A novel murine model for contact lens wear reveals clandestine IL-1R dependent corneal parainflammation and susceptibility to microbial keratitis upon inoculation with Pseudomonas aeruginosa.
Metruccio MME; Wan SJ; Horneman H; Kroken AR; Sullivan AB; Truong TN; Mun JJ; Tam CKP; Frith R; Welsh L; George MD; Morris CA; Evans DJ; Fleiszig SMJ
Ocul Surf; 2019 Jan; 17(1):119-133. PubMed ID: 30439473
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Pseudomonas keratitis in humans.
Hessburg PC
Am J Ophthalmol; 1966 May; 61(5 Pt 1):896-903. PubMed ID: 16874993
[TBL] [Abstract][Full Text] [Related]
17. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses.
Hui A; Willcox M; Jones L
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4896-904. PubMed ID: 25028363
[TBL] [Abstract][Full Text] [Related]
19. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane transplantation.
Mattila JS; Korsbäck A; Krootila K; Holopainen JM
Acta Ophthalmol; 2013 Aug; 91(5):e410-1. PubMed ID: 23844860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
